UPDATE 2-European shares log fifth week of gains, Novo Nordisk shines
European stocks clocked their fifth
straight week of gains on Friday with investors buying into the
oil and gas and banking sectors, and Novo Nordisk rising after
U.S. approval of its oral diabetes drug.